These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2455911)

  • 1. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
    Cooper EH; Siddall JK; Newling DW; Robinson MR
    Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
    Bauer HW
    Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J; de Torres Mateos JA; Soler-Roselló A
    Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
    Jenkins D; Jones RT; Clarke AM
    Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.
    Rubenstein M; Guinan PD; McKiel CF; Dubin A
    Clin Physiol Biochem; 1988; 6(5):241-52. PubMed ID: 2465864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer.
    Cohen RJ; Glezerson G; Haffejee Z
    Arch Pathol Lab Med; 1992 Jan; 116(1):65-6. PubMed ID: 1370878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of the serum determination of specific prostatic antigen in the prediction of prostatic cancer].
    Morote Robles J; Ruibal Morell A; Pont Salvadó A
    Actas Urol Esp; 1988; 12(1):10-4. PubMed ID: 2455436
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between reactivation and tumor markers in prostatic cancer].
    Fuse H; Umeda K; Kazama T; Sakamoto M; Sakai T; Fujishiro Y; Mizuno I; Katayama T
    Hinyokika Kiyo; 1991 Jan; 37(1):39-43. PubMed ID: 1707217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
    Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
    Svanholm H; Hørder M
    Scand J Urol Nephrol Suppl; 1988; 107():65-70. PubMed ID: 2453920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
    Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
    Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
    [No Abstract]   [Full Text] [Related]  

  • 16. PSA and PAP as immunohistochemical markers in prostate cancer.
    Epstein JI
    Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histochemistry and quantitative microscopy of prostate cancer.
    Bennett BD
    Prog Clin Biol Res; 1987; 239():711-58. PubMed ID: 2443917
    [No Abstract]   [Full Text] [Related]  

  • 18. Economics of screening for carcinoma of the prostate.
    Optenberg SA; Thompson IM
    Urol Clin North Am; 1990 Nov; 17(4):719-37. PubMed ID: 1699340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J
    Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of prostate-specific antigen].
    Wirth M
    Urologe A; 1991 May; 30(3 Suppl):6. PubMed ID: 1720907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.